EMEA-002875-PIP01-20

Table of contents

Key facts

Active substance
Allogeneic skin-derived ATP-binding cassette, sub-family B, member 5 (ABCB5)-positive mesenchymal stem cells (allo-APZ2-EB)
Therapeutic area
Dermatology
Decision number
P/0247/2021
PIP number
EMEA-002875-PIP01-20
Pharmaceutical form(s)
Suspension for injection
Condition(s) / indication(s)
Treatment of epidermolysis bullosa
Route(s) of administration
Intravenous use
Contact for public enquiries
RHEACELL GmbH & Co. KG

Tel: +49 6221718330
Email: office@rheacell.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating